Insights
Medical device quality, design transfer, and supplier control for companies manufacturing in Asia.
QMSR, Design Controls
510(k)-Exempt Does Not Automatically Mean QMSR-Exempt
Exemption from premarket notification is not exemption from the quality system. The two decisions are made under different parts of the regulation, and confusing them is the most common reason a Class II device company arrives at an audit without a defensible design file.
August 2026 · 6 min read
-
Design Controls, Supplier Management
Who Owns the Design File When Your Asian Factory Designed the Product?
The factory drew it, tooled it, and knows why every dimension is what it is. Your name is on the label. Regulators will ask you for the design file, and "the supplier has it" is not an answer that survives an inspection.
August 2026 · 7 min read
-
Audit Readiness, Evidence
The 80-Document Trap: Procedures Are Not Executed Evidence
A complete index of approved procedures feels like readiness. It is not. An auditor will pick one procedure and ask to see the records it produced last quarter, and that is where most quality systems come apart.
July 2026 · 6 min read
-
Design Transfer, Supplier Quality
How to Move a Class II Device to a New China Manufacturer Without Backdating
Transfers go wrong in a specific, predictable way: the product ships from the new factory before the evidence that qualifies the new factory exists. Then someone is asked to sign a document with a date that has already passed.
July 2026 · 8 min read
-
Risk Management, Verification
What a Heating-Pad Fold Test Reveals About Risk, Verification, and Supplier Control
A heating pad folded in half is a smaller radiating surface carrying the same power. That is a foreseeable use condition, and the chain from foreseeable use to a production test is exactly what a design file is supposed to contain.
June 2026 · 7 min read
-
QMSR, Quality Systems
Converting a Legacy Part 820 Checklist to the 2026 QMSR
Most companies still hold a checklist organized around the old Part 820 subparts. The underlying obligations largely survived the transition, but the vocabulary and structure did not, and a stale index makes real gaps invisible.
June 2026 · 7 min read
-
Supplier Audits, Compliance
Why Medical Device Companies Need Annual Supplier Audits in China
Annual on-site audits are not just a best practice for medical device manufacturers relying on China-based suppliers. Remote monitoring alone does not demonstrate the supply-chain control that ISO 13485 and FDA requirements expect.
January 2025 · 3 min read
-
ISO 13485, Quality Systems
Understanding ISO 13485:2016 Requirements for Chinese Suppliers
Ensuring ISO 13485 compliance at a Chinese supplier requires more than reviewing certificates. It demands on-site verification that the factory follows the systems documented in its own quality manual.
December 2024 · 3 min read
-
Pharmaceutical, GMP, Compliance
GMP Compliance for Pharmaceutical Component Suppliers in China
Pharmaceutical and biotechnology companies sourcing components and packaging from China face GMP obligations that are non-negotiable, and on-site audits remain the primary tool for verifying them.
November 2024 · 3 min read
Facing one of these problems?
We help U.S. medical device companies control outsourced development and manufacturing in Asia.